Notices. SECURITIES AND EXCHANGE COMMISSION

291 words·~1 min read·/register/2014/05/07/2014-10553

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 8011-01-P SECURITIES AND EXCHANGE COMMISSION [ File No. 500-1] In the Matter of: Genosys, Inc.: Order of Suspension of Trading May 5, 2014. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of GeNOsys, Inc. (“Genosys”) because Genosys has not submitted the following required periodic filings: Filing Due date Annual report on Form 10-K for period ended Nov. 30, 2011 February 28, 2012.

Quarterly report on Form 10-Q for period ended Feb. 29, 2012 April 16, 2012. Quarterly report on Form 10-Q for period ended May 31, 2012 July 16, 2012. Quarterly report on Form 10-Q for period ended August 31, 2012 October 15, 2012. Annual report on Form 10-K for period ended Nov. 30, 2012 February 28, 2013. Quarterly report on Form 10-Q for period ended Feb. 28, 2013 April 15, 2013. Quarterly report on Form 10-Q for period ended May 31, 2013 July 15, 2013. Quarterly report on Form 10-Q for period ended August 31, 2013 October 15, 2013.

Annual report on Form 10-K for period ended Nov. 30, 2013 February 28, 2014. Quarterly report on Form 10-Q for period ended Feb. 28, 2013 April 14, 2014. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. *Therefore, it is ordered,* pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m.

EDT on Monday, May 5, 2014 through 11:59 p.m. EDT on May 16, 2014. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2014-10553 Filed 5-5-14; 11:15 am]